AsiaBiome is an US company using Asia-sourced data to accelerate the discovery of microbiome based therapeutics. We create IP for a new class of drugs to license to large Pharma companies globally.
We launched in 2018, building Asia's first comprehensive microbiome discovery platform. In partnership with the leading stool microbiota bank in Asia, we've built a platform to aggregate clinical data and samples from five different countries in Asia.
PLATFORM PARTNERS & COMPONENTS
Comprehensive | Accelerated | Discovery
FECAL MICROBIOTA TRANSPLANTS
The Gut Microbiome Intervention
Big Data Driven Drug Discovery